With the Metaverse on the way, an AI Bill of Rights is urgent

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Industry analyst discusses biotech firm lifecycle

Broad Institute, Intel, Google Advance Biomedical Research

Microsoft’s next moves: Biz dev and strategy leader Christopher Young is focusing on these key areas

How AI simplifies data management for drug discovery

The Coming Age for Tech x Bio: The “Industrial Bio Complex”

European Biotech Investors Cap Off Record Year in Fundraising

Family Offices Become Serious Rivals to VC Firms

Ronald Cohen: “Mesurons l’impact comme on mesure les profits”